股腘段编织型镍钛支架与药物洗脱支架的倾向性匹配分析
本研究基于前瞻性机构数据库,纳入2013至2018年296例股腘段经皮腔内血管成形术(PTA)患者,比较仿生镍钛支架(SPS)与药物洗脱支架(DES)的中期疗效。倾向性匹配121对后,两组在靶病变再狭窄、支架闭塞、大截肢、再干预及死亡方面均无显著差异,且斑块钙化未预测再狭窄或闭塞。
要点
- 匹配后SPS与DES在靶病变再狭窄>50%上无显著差异(31% vs 27%,p=.34)。
- 两组支架闭塞(13% vs 12%,p=.85)及二次通畅率(87% vs 88%)相当。
- 斑块钙化在匹配及非匹配人群中均未预测再狭窄或闭塞。
核心结论
- 股腘段PTA使用SPS或DES的中期结果相当,不受斑块钙化和患者特征影响。
研究设计与样本
- 回顾性分析前瞻性机构数据库,纳入2013至2018年296例连续股腘段PTA患者,平均年龄73岁(SD 11),65%男性,68%为慢性肢体威胁性缺血。
- 基于患者和斑块(含CT斑块特征)数据构建倾向性评分,创建121对匹配病例。
主要发现
- 中位两年随访期间,全队列28%发生靶病变再狭窄>50%(SPS 32% vs DES 24%,p=.07)。
- 匹配队列中SPS vs DES的靶病变再狭窄>50%(31% vs 27%,p=.34)、支架闭塞(13% vs 12%,p=.85)、大截肢(10% vs 6%,p=.16)、再干预(14% vs 9%,p=.12)及死亡(7% vs 4%,p=.31)均无显著差异。
- 匹配队列二次通畅率SPS 87% vs DES 88%。
- 多变量分析显示两年再狭窄>50%的主要预测因素为女性(OR 2.05,p=.01)、高血压(OR 2.10,p=.04)和既往股腘段闭塞(OR 1.35,p=.04)。
临床怎么用
- 在股腘段PTA中,SPS与DES的中期疗效相当,支架选择可综合考虑斑块钙化及患者特征。
- 女性、高血压及既往股腘段闭塞患者再狭窄风险较高,需加强随访。
局限性
- 原文未报告具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Percutaneous transluminal angioplasty (PTA) is a common procedure in patients with peripheral arterial disease (PAD) affecting the femoropopliteal segment (F-P). Biomimetic nitinol stents (Supera peripheral stent, SPS) and drug eluting stents (DES) were designed to improve the longevity of F-P PTA; however, their performance has not been compared in a pragmatic setting, taking atherosclerotic plaque characteristics into account. METHODS: Overall, 296 consecutive patients (mean age: 73 y, SD: 11 y, 65% male, 68% with chronic limb threatening ischaemia) who underwent F-P PTA using SPS or DES between 2013 and 2018 were identified from a prospectively maintained institutional database. Patient and plaque characteristics, including F-P plaque characterisation based on computed tomography, were collected; 121 case matched pairs were created using a propensity score based on patient and plaque data. RESULTS: During the median two year follow up, 28% of the cohort (32% SPS vs. 24% DES, p = .07) developed target lesion restenosis (TLR) > 50%. Among the 121 case matched pairs of patients, those with SPS vs. DES were not significantly more likely to develop TLR >50% (31% vs. 27%, p = .34), or stent occlusion (13% vs. 12%, p = .85 - secondary patency rate 87% vs. 88%), have a major amputation (10% vs. 6%, p = .16), require re-intervention (14% vs. 9%, p = .12), or die (7% vs.4%, p = .31). Plaque calcification did not predict restenosis or occlusion in either stent group, both in the matched and non matched populations. Multivariable analysis adjusted for patient and plaque characteristics revealed that the main predictors of restenosis >50% at two years were female sex [odds ratio (OR): 2.05, p = .01], hypertension (OR: 2.10, p = .04) and previous F-P occlusion (OR: 1.35, p = .04). CONCLUSION: Medium term results following F-P PTA with either SPS or DES are comparable, regardless of plaque calcification and patient characteristics.
引用
- Saratzis A, Rudarakanchana N, Patel S, et al. Interwoven Nitinol Stents versus Drug Eluting Stents in the Femoro-Popliteal Segment: A Propensity Matched Analysis. Eur J Vasc Endovasc Surg. 2019. PMID: 31500990. doi:10.1016/j.ejvs.2019.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。